Radiomics for prediction of survival in lower-grade gliomas-it's time to move beyond the crystal ball

Abstract

Radiomics might help predict survival of patients with lower-grade gliomas. Several different models using different radiomics features have been proposed with only little overlap in included features. Prospective trials and validation studies are needed to establish which models offer clinical benefit and which do not.